Don't Forget About the Flu! Identifying, Treating, and Protecting High-Risk Patients
Faculty:
James S. Lewis II, PharmD, FIDSA
Infectious Diseases Pharmacy Supervisor
Co-Director of Antibiotic Stewardship
Departments of Pharmacy and Infectious Diseases
Oregon Health & Science University
Portland, OR
Schedule:
6:15 pm - 6:30 pm CT - NISHP Business Meeting
6:30 pm - 7:30 pm CT - Presentation
Registration:
This event is available to ICHP members at no charge. You must register online in advance to attend this program.
Location:
Virtual Meeting through Zoom
Learning Objectives:
At the conclusion of this knowledge-based continuing pharmacy education activity, pharmacist participants should be able to:
- Identify appropriate candidates for antiviral therapy based on risk for influenza-related complications, in accordance with current guideline recommendations
- Differentially diagnose influenza based on clinical presentation and accurate interpretation of appropriate diagnostic tests when necessary
- Recommend individualized antiviral treatment plans for patients with influenza based on current data and unique agent characteristics
- Advise on influenza prophylaxis based on evidence and in accordance with guideline recommendations
At the conclusion of this knowledge-based continuing pharmacy education activity, pharmacy technician participants should be able to:
- Identify appropriate candidates for antiviral therapy based on risk for influenza-related complications, in accordance with current guideline recommendations
- Differentially diagnose influenza based on clinical presentation and accurate interpretation of appropriate diagnostic tests when necessary
- Recommend individualized antiviral treatment plans for patients with influenza based on current data and unique agent characteristics
- Advise on influenza prophylaxis based on evidence and in accordance with guideline recommendations
This activity is jointly provided by Educational Review Systems, Inc and Paradigm Medical Communications, LLC.
Accreditation:
Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit for 1.0 contact hours (0.10 CEU) submitted to CPE Monitor as early as 14 days after the event and no later than 60 days after the event. Please know that if accurate e-Profile information is not pro-vided within 60 days of the event, credit cannot be claimed after that time. The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days.
UAN # 0761-9999-21-293-L01-P; 0761-9999-21-293-L01-T
This is a knowledge-based activity.
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
Target Audience: This knowledge-based activity was developed for Health-System Pharmacists and Pharmacy Technicians
Faculty Disclosure: It is the policy of ICHP to ensure balance, independence, objectivity, and scientific rigor in all of its education programs. In accordance with this policy, faculty must disclose to the participants any significant relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of these continuing pharmacy education programs. Any resident or fellow presentation is reviewed by a content specialist preceptor. These disclosures will be available at the program.
Policy and Procedure for Educational Program Grievances can be found on our website.
PTCB requires CPhTs to submit 20 hours of pharmacy technician-specific (‘T-specific’) continuing pharmacy education (CPE) to qualify for recertification. Please advise all pharmacy technicians at your site of this change. As an ACPE accredited provider, ICHP will continue to include Technician specific programming in most if not all of our CPE programming.
